Diagnostik, Prothesen, Impfstoffe, Genomik: die Medizin, die Lebensjahre gewinnt.
Medizin, die Lebensjahre gewinnt: KI-gestützte Vorsorge, die Millionen Patienten untersucht, Impfstoffe der neuen Generation, Genomik auf dem Weg von der Sequenzierung zur Therapie, Prothesen und Implantate, die verlorene Fähigkeiten zurückgeben. Die Rubrik verfolgt abgeschlossene klinische Studien, Marktzulassungen, Einführungen in Kliniken — den Moment, in dem eine Technologie aufhört, ein Paper zu sein, und zur Versorgung wird.
Die Zahlen entscheiden: Kohorten, Erkennungsraten, vermiedene Sterblichkeit, Kosten. Wir berichten gern über Gesundheitssysteme, die im großen Maßstab einführen — Indien, Brasilien, Südostasien —, weil sich sparsame Technologien oft dort bewähren, bevor sie anderswo ankommen. Jeder Artikel stützt sich auf die Studie, die Zulassung oder die Untersuchung dahinter — und nennt sie.
Researchers in Japan built a 3D human heart model of HFpEF, where the heart relaxes poorly despite normal contraction.
AEA kept rising through the marathon and remained elevated after 45 minutes of recovery.
Alternative splicing creates a longer kindlin-3 form that recruits more effectively to the cell membrane.
The model also showed less aggressive cells becoming mobile after they detached from neighboring cells and entered small tissue spaces.
The oral drug BI6674 reduced tumors in a genetically engineered mouse model.
Eleven left-hemisphere stroke patients were tested on familiar tool use and physical reasoning.
Pterostilbene, found in berries, boosted fat breakdown in cultured C2C12 mouse muscle cells.
The mice developed Rett-like breathing after MECP2 was blocked in oxygen-sensing cells beside the carotid artery.
The material combines more than 75% ceramic and zirconia filler by weight.
Penn Medicine’s phase 1 study is the first U.S. human test of conformal FLASH proton therapy.
ADAMTSL4 levels rose in mice and patients with colorectal or lung cancer who had cachexia.
The coding system scores praise, questions, commands and frustration in short recordings.
The clocks were built from 104,208 adults and 172 routine clinical indicators across three Chinese centers.
The result comes from aged mice, not human patients, and was reported in Nature Aging.
NTNU's model used age, sex and 60 health variables without seeing headache symptoms.
The atlas profiles 94,451 cells from children with Crohn’s disease and compares them with noninflammatory controls.
Two antibodies blocked allergic IgE from attaching to alpha-gal allergens in laboratory tests.
CondenScreen uses MLF2, a biomarker found across dysfunctional condensates, rather than disease-specific markers.